Larry Hayward

2.5k total citations
31 papers, 684 citations indexed

About

Larry Hayward is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Larry Hayward has authored 31 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Larry Hayward's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Larry Hayward is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Larry Hayward collaborates with scholars based in United Kingdom, United States and France. Larry Hayward's co-authors include David J. Harrison, Jayne Culley, Bernard Ramsahoye, Pat R. R. Langridge‐Smith, C. Logan Mackay, Duncan Sproul, Tom Latham, Nick Gilbert, Haruyuki Takemura and Yves Pommier and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Larry Hayward

28 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larry Hayward United Kingdom	11	350	168	124	111	90	31	684
Soo‐Yeon Park South Korea	17	508 1.5×	154 0.9×	142 1.1×	155 1.4×	71 0.8×	51	809
Zhitu Zhu China	17	595 1.7×	195 1.2×	177 1.4×	109 1.0×	84 0.9×	46	943
Marjo de Graauw Netherlands	16	652 1.9×	167 1.0×	176 1.4×	72 0.6×	133 1.5×	23	1.0k
Ting-Ting Chao Taiwan	12	539 1.5×	207 1.2×	93 0.8×	152 1.4×	62 0.7×	21	779
Tsung‐Han Hsieh Taiwan	19	522 1.5×	166 1.0×	165 1.3×	228 2.1×	70 0.8×	55	1.1k
Anne John United Arab Emirates	14	397 1.1×	140 0.8×	66 0.5×	85 0.8×	98 1.1×	48	841
Sudeh Izadmehr United States	18	629 1.8×	233 1.4×	124 1.0×	98 0.9×	78 0.9×	29	1.0k
Hefen Yu China	17	486 1.4×	133 0.8×	191 1.5×	114 1.0×	46 0.5×	44	735
Yuli Wang China	11	468 1.3×	212 1.3×	150 1.2×	107 1.0×	66 0.7×	23	736

Countries citing papers authored by Larry Hayward

Since Specialization

Citations

This map shows the geographic impact of Larry Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Hayward more than expected).

Fields of papers citing papers by Larry Hayward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Hayward. The network helps show where Larry Hayward may publish in the future.

Co-authorship network of co-authors of Larry Hayward

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Hayward. A scholar is included among the top collaborators of Larry Hayward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Hayward. Larry Hayward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pizzagalli, Mattia D., Owen P. Leary, Daniel J. Lee, et al.. (2025). Inhibition of HDAC7 reprograms the histone H3.3 landscape to induce heterochromatin spreading and DNA replication defects in cancer cells. Journal of Biological Chemistry. 301(10). 110732–110732. 1 indexed citations

Danks, Mary K., John P. Thomson, Morwenna Muir, et al.. (2025). Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma. Molecular Oncology. 19(11). 3223–3242.

Gottipati, Srikanth, Helena Earl, Christina Yau, et al.. (2023). 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study. Annals of Oncology. 34. S325–S326. 1 indexed citations

Azfer, Asim, Alison Meynert, Donald M. Salter, et al.. (2022). Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease. BMC Medical Genomics. 15(1). 128–128. 4 indexed citations

Macnaught, Gillian, Olga Oikonomidou, Christopher T. Rodgers, et al.. (2021). Cardiac Energetics Before, During, and After Anthracycline-Based Chemotherapy in Breast Cancer Patients Using 31P Magnetic Resonance Spectroscopy: A Pilot Study. Frontiers in Cardiovascular Medicine. 8. 653648–653648. 4 indexed citations

Salter, Donald M., Morwenna Muir, Jayne Culley, et al.. (2019). Development of mouse models of angiosarcoma driven by p53. Disease Models & Mechanisms. 12(7). 15 indexed citations

Ali, Hager R., A. Dariush, Jeremy Thomas, et al.. (2017). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. Annals of Oncology. 28(8). 1832–1835. 31 indexed citations

Palmieri, Carlo, Robert C. Stein, Xinxue Liu, et al.. (2017). IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment. 165(2). 343–353. 41 indexed citations

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2015). Abstract PD2-3: ARTemis: A randomised trial of bevacizumab with neo-adjuvant chemotherapy for patients with HER2-negative early breast cancer. Cancer Research. 75(9_Supplement). PD2–3.

10.

Fumoleau, P., Kevin M. Koch, Étienne Brain, et al.. (2014). A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study). The Breast. 23(5). 663–669. 10 indexed citations

11.

Frezza, Anna Maria, Charlotte Benson, Ian Judson, et al.. (2014). Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience. PubMed. 4(1). 7–7. 41 indexed citations

12.

Hendifar, Andrew, Sant P. Chawla, Michael Leahy, et al.. (2013). Results of the randomized phase III trial of trabectedin (T) versus doxorubicin-based chemotherapy (DXCT) as first-line therapy in patients (pts) with translocation-related sarcoma (TRS).. Journal of Clinical Oncology. 31(15_suppl). 10517–10517. 7 indexed citations

13.

Latham, Tom, C. Logan Mackay, Duncan Sproul, et al.. (2012). Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Research. 40(11). 4794–4803. 266 indexed citations

14.

MacLaine, Nicola J., Caroline O. Michie, Pavla Bouchalová, et al.. (2012). Anterior Gradient-3: A novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models. Journal of Immunological Methods. 378(1-2). 20–32. 42 indexed citations

15.

Earl, Helena, David Cameron, John M.S. Bartlett, et al.. (2012). ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer.. Journal of Clinical Oncology. 30(15_suppl). TPS1144–TPS1144. 2 indexed citations

16.

Hengel, Shawna, Euan Murray, Simon P. Langdon, et al.. (2011). Data-independent Proteomic Screen Identifies Novel Tamoxifen Agonist that Mediates Drug Resistance. Journal of Proteome Research. 10(10). 4567–4578. 40 indexed citations

17.

Hayward, Larry, et al.. (2006). Development of a strategy to successfully convert an ambulatory infusion center from epoetin alfa to darbepoetin alfa.. PubMed. 3(6 Suppl 4). 8–9. 1 indexed citations

18.

Murray, Euan, et al.. (2006). Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53. Breast Cancer Research. 8(S2). 1 indexed citations

19.

Meng, Linghua, Hongliang Zhang, Larry Hayward, et al.. (2004). Tetrandrine Induces Early G1 Arrest in Human Colon Carcinoma Cells by Down-Regulating the Activity and Inducing the Degradation of G1-S–Specific Cyclin-Dependent Kinases and by Inducing p53 and p21Cip1. Cancer Research. 64(24). 9086–9092. 102 indexed citations

20.

Davidson, Richard, Larry Hayward, J C Pounsford, & K.B. Saunders. (1986). Lung Function and Within-breath Changes in Resistance in Patients who have had a Laryngectomy. QJM. 60(232). 753–62. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact